Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share


Therapeutic Areas: Pulmonary/Respiratory Diseases

Idiopathic Pulmonary Fibrosis Clinical Trials


A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham - Division of Pulmonary, Allergy & Criticial Care

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham : University of Alabama at Birmingham

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Birmingham : The Kirklin Clinic

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Arizona

Phoenix : Arizona Pulmonary Specialists

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Phoenix : St. Joseph's Hospital and Medical Center - Heart Lung Institute/ Clinical Research

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix : Arizona Pulmonary Specialists, Ltd.

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix : Saint Joseph's Hospital and Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

View More »

Scottsdale : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Scottsdale : Mayo Clinic Arizona

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Scottsdale : Arizona Pulmonary Specialists, Ltd.

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Scottsdale : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Scottsdale : Arizona Pulmonary Specialists, LTD

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Tucson : University of Arizona

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Tucson : The University of Arizona

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

California

San Francisco : University California-San Francisco Updated

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Stanford : Stanford University Medical Center

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

La Jolla : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

La Jolla : University of California San Diego

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

La Jolla : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Los Angeles : VA Greater LA Health Care System-UCLA

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles : Cedars-Sinai Medical Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles : David Geffen School of Medicine at UCLA

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles : David Geffen School of Medicine at University of California, Los Angeles

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles : David Geffen School of Medicine UCLA

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease or Pulmonary Hypertension

Los Angeles : David Geffen School of Medicine, UCLA

Patients are needed to participate in a clinical research study evaluating treprostinil for the treatment of Pulmonary Arterial Hypertension, Interstitial Lung Disease or Idiopathic Pulmonary Fibrosis

Los Angeles : David Geffen School of Medicine UCLA

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles : Departments of Pulmonary and Critical Care, Cardiothoracic Surgery and Infectious Diseases at David Geffen School of Medicine at UCLA

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Sacramento : University of California- Davis Medical Center

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Sacramento : University of California Davis Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Sacramento : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Sacramento : UC Davis Medical Center

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

San Francisco : University of California at San Francisco

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

San Francisco : University of California San Francisco

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Santa Barbara : Sansum Clinic

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Stanford : Stanford University Medical Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Stanford : Stanford University Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Colorado

Denver : National Jewish Health

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Denver : National Jewish Health

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Denver : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Denver : National Jewish Health

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Wheat Ridge : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Connecticut

Danbury : 1199.187.01007 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

New Haven : Yale University School of Medicine, Section of Pulmonary & Critical Care

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

New Haven : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

New Haven : Yale University School of Medicine

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New Haven : Yale University

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Florida

Gainesville : University of Florida/Pulmonary, Critical Care & Sleep Medicine

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Miami : University of Miami

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Clearwater : Bay Area Chest Physicians/Research Alliance, Inc.

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Clearwater : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Clearwater : Bay Area Chest Physicians

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Daytona Beach : Advanced Pulmonary & Sleep Research Institute of Florida

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Jacksonville : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Jacksonville : University of Florida

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Jacksonville : Mayo Clinic Florida

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Miami : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Miami : University of Miami

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Miami : Interdisciplinary Stem Cell Institute / University of Miami

A clinical trial to evaluate treatments using Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) and matched placebo for patients with Idiopathic Pulmonary Fibrosis (IPF)

Miami : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Orlando : Central Florida Pulmonary Group, PA

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Sarasota : Sarasota Memorial Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Sarasota : 1199.187.01009 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Tampa : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Tampa : Tampa General Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Tampa : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Tampa : Tampa General Hospital

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Weston : Cleveland Clinic Florida- Weston Hospital

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Weston : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Weston : Cleveland Clinic Florida

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Winter Park : Florida Pulmonary Research Institute

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Winter Park : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Georgia

Atlanta : The Emory Clinic

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Atlanta : Emory University Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Atlanta : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Atlanta : Emory University

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Austell : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Hawaii

Honolulu : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Illinois

Chicago : University of Chicago

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Chicago : University of Chicago

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Chicago : Northwestern University

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Chicago : Rush University Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Chicago : University of Chicago

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Chicago : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Chicago : Northwestern University

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Maywood : Loyola University Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Skokie : 1199.187.01015 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Iowa

Council Bluffs : Loess Hills Clinical Research Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Iowa City : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Iowa City : University of Iowa Hospitals and Clinics

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Kansas

Wichita : Via Christi Research

FG-3019 for Idiopathic Pulmonary Fibrosis

Wichita : Via Christi Research

Lebrikizumab for Idiopathic Pulmonary Fibrosis

Wichita : Via Christi Research

LPA Antagonist for Idiopathic Pulmonary Fibrosis

View More »

Additional Locations : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Kansas City : University of Kansas Medical Center

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Wichita : Via Christi Clinic

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Wichita : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Wichita : Via Christi Clinic, P.A.

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Kentucky

Lexington : 1199.187.01033 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Louisville : Kentuckiana Pulmonary Associates

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Louisville : University of Louisville

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Louisville : Kentuckiana Pulmonary Associates

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Louisville : University of Louisville

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Louisville : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Louisville : University of Louisville

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Louisiana

New Orleans : Tulane University

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

New Orleans : Tulane University School of Medicine

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Maine

Portland : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Maryland

Baltimore : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Baltimore : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Baltimore : University of Maryland

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Massachusetts

Boston : Brigham and Women's Hospital

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Boston : Massachusetts General Hospital

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Boston : Brigham & Women's Hospital -Pulmonary and Critical Care Medicine

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Boston : Beth Israel Deaconess Medical Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Boston : Brigham and Women's Hospital

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Boston : Beth Israel Deaconess Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Boston : Brigham and Women's Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Boston : Tufts University School of Medicine

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Boston : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Boston : Steward St. Elizabeth's Medical Center

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Michigan

Ann Arbor : University of Michigan Health System

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Ann Arbor : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Detroit : Henry Ford Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Minnesota

Minneapolis : University of Minnesota

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Minneapolis : University of Minnesota Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Minneapolis : 1199.187.01002 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Rochester : Mayo Clinic, Pulmonary Clinical Research Unit

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Rochester : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Rochester : Mayo Clinic

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Rochester : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Missouri

Chesterfield : CardioPulmonary Research Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Chesterfield : CardioPulmonary Associates

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Chesterfield : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Chesterfield : St. Luke's Hospital

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Kansas City : Saint Luke's Midwest Pulmonary Consultants

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

St. Louis : Washington University School of Medicine

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

St. Louis : Washington University School of Medicine

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

St. Louis : Washington University School of Medicine

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New Hampshire

Lebanon : Dartmouth-Hitchcock Medical Center Pulmonary Dept.

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Lebanon : Dartmouth-Hitchcock Medical Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Lebanon : Dartmouth Hitchcock Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Lebanon : 1199.187.01008 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

New Jersey

Brunswick : Robert Wood Johnson Medical School

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

New Brunswick : Robert Wood Johnson Medical School

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New Brunswick : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Newark : University of Medicine and Dentistry of New Jersey

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Summit : Pulmonary & Allergy Associates, PA

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Summit : Pulmonary and Allergy Associates, PA

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Summit : Pulmonary & Allergy Associates, P.A.

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New York

View More »

Albany : Albany Medical College

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Forest Hills : ISA Clinical Research

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Jamaica : Jamaica Hospital Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Mineola : 1199.187.01011 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

New Hyde Park : North Shore University Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New York : Weill Cornell Medical College

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

New York : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

New York : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

New York : Mount Sinai School of Medicine

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New York : Columbia University

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New York : Weill Cornell Medical College

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New York : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Rochester : Highland Hospital

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Rochester : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Rochester : Highland Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

North Carolina

Asheville : Asheville Pulmonary and Critical Care Associates, P.A.

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Durham : Duke University Medical Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Durham : Duke University Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Durham : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Ohio

Cleveland : Cleveland Clinic Updated

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Cincinnati : The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Cincinnati : University of Cincinnati Pulmonary, Critical Care & Sleep Medicine

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Cincinnati : University of Cincinnati

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Cincinnati : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Cincinnati : University of Cinncinati

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Cleveland : Cleveland Clinic

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Cleveland : Cleveland Clinic

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Cleveland : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Cleveland : Cleveland Clinic

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Cleveland : Cleveland Clinic

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Columbus : Ohio State University, Martha Morehouse Medical Plaza

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Columbus : The Ohio State University

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Columbus : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Columbus : Ohio State University

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Columbus : The Ohio State University

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Dayton : Miami Valley Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Toledo : 1199.187.01004 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Oklahoma

Oklahoma City : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Oregon

Portland : The Oregon Clinic

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Portland : Oregon Health Science University

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Portland : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Portland : The Oregon Clinic, PC

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Portland : 1199.187.01014 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Pennsylvania

Pittsburgh : University of Pittsburgh Medical Center

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Philadelphia : Temple Lung Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Philadelphia : University of Pennsylvania

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Philadelphia : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Philadelphia : Thomas Jefferson University Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Philadelphia : University of Pennsylvania

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Philadelphia : Temple University Hospital, Temple Lung Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Philadelphia : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Pittsburgh : Allegheny General Hospital

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Pittsburgh : University of Pittsburgh Medical Center - Simmons Center for Interstitial Lung Disease

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Pittsburgh : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Pittsburgh : University of Pittsburgh Presbyterian - Montefiore

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Pittsburgh : University of Pittsburgh Medical Center

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Rhode Island

Providence : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

South Carolina

Charleston : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Charleston : Medical University of South Carolina

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Charleston : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Charleston : 1199.187.01042 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Tennessee

Nashville : Vanderbilt University Medical Center

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Nashville : Vanderbilt University Medical Center

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Nashville : Vanderbilt University

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Nashville : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Nashville : Vanderbilt University Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Nashville : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Nashville : 1199.187.01001 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Nashville : Vanderbilt University

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Texas

Houston : Baylor College of Medicine and The Methodist Hospital

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

Dallas : UT Southwestern Medical Center

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Dallas : University of Texas Southwestern Medical Center - Dallas

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Dallas : 1199.187.01016 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Edinburg : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Houston : Baylor College of Medicine

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Houston : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Houston : Baylor College of Medicine

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

McKinney : Metroplex Pulmonary and Sleep Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

McKinney : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

San Antonio : Alamo Clinical Research

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Tyler : University of Texas Health Science Center at Tyler

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Utah

Salt Lake City : University of Utah

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Salt Lake City : University of Utah

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Salt Lake City : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Salt Lake City : University of Utah

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Salt Lake City : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

View More »

Salt Lake City : University of Utah - Lung Health Research

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Vermont

Colchester : Vermont Lung Center

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Colchester : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Colchester : Vermont Lung Center

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Virginia

Falls Church : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Falls Church : Inova Fairfax Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Richmond : Virginia Commonwealth University Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Washington

Everett : Providence Everett Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Seattle : University of Washington

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Tacoma : MultiCare Pulmonary Specialists

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Tacoma : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Wisconsin

Madison : University of Wisconsin Hospital & Clinics

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Madison : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Milwaukee : Aurora St. Luke's Medical Center

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Milwaukee : Froedtert Hospital and Medical College of Wisconsin

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Australia

Adelaide : Royal Adelaide Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Box Hill : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Box Hill : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Camperdown : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Camperdown : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

View More »

Chermside : Prince Charles Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Concord : Concord Repatriation General Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Concord : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Darlinghurst : Saint Vincents Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Darlinghurst : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Frankston : Peninsula Health

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Frankston : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Herston : Royal Brisbane and Women's Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Melbourne : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Melbourne : The Alfred Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Nedlands : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Nedlands : Sir Charles Gairdner Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New Lambton : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Parkville : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Perth : Royal Perth Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Prahran : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Toorak Gardens : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Woodville South : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Belgium

Anderlecht : ULB Erasme

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Bruxelles : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Edegem : GSK Investigational Site

A clinical research study of No Intervention for the treatment of Idiopathic Pulmonary Fibrosis

Leuven : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Leuven : Universitair Ziekenhuis Leuven

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Yvoir : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Yvoir : Cliniques Universitaires UCL de Mont-Godinne

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Canada

Edmonton : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Edmonton : 1199.187.02004 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Halifax : 1199.187.02003 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Hamilton : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Hamilton : 1199.187.02002 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

View More »

Kelowna : Kelowna Respiratory and Allergy Clinic

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Moncton : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Montreal : Centre Hospitalier de L'Université de Montréal Hôtel-Dieu

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Montreal : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Quebec : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Quebec City : Institut Universitaire de Cardiologie et de Pneumologie de Québec

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Sherbrooke : 1199.187.02008 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Toronto : University Health Network

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Toronto : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Vancouver : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Vancouver : University of British Columbia

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Vancouver : University of British Columbia

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Vancouver : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Vancouver : 1199.187.02005 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Vancouver : 1199.187.02007 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Windsor : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Winnipeg : 1199.187.02001 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

China

Beijing : Peking Union Medical College Hospital

A clinical trial to evaluate treatments using Pirfenidone and Placebo for patients with Idiopathic Pulmonary Fibrosis

Czech Republic

Brno : Fakultní nemocnice Brno

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Jihlava : Nemocnice Jihlava

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Liberec : Krajská nemocnice Liberec a.s.

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Ostrava - Poruba : Fakultní Nemocnice Ostrava

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Plzen : Fakultní nemocnice Plzen

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Prague 4 - Krc : Thomayerova nemocnice

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Ústí nad Labem : Masarykova nemocnice v Ústí nad Labem o.z.

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

France

Bobigny : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Bobigny Cedex : Centre Hospitalier Universitaire Hôpital Avicenne

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Bron : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Bron : Hôpital Louis Pradel

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Grenoble Cedex 9 : Centre Hospitalier Universitaire Grenoble Hopital Michalon

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Lille cedex : Hôpital Albert Calmette

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Marseille Cedex 20 : Centre Hospitalier Universitaire Hôpital Nord

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Montpellier cedex 5 : Hôpital Arnaud de Villeneuve

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Nice CEDEX 1 : Centre Hospitalier Universitaire de Nice-Hôpital Pasteur

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Paris : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Paris : Hôpital Bichat-Claude Bernard

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Paris Cedex 15 : HEGP

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Rennes : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Rennes cedex 9 : Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Strasbourg : Hôpitaux Universitaires de Strasbourg

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Tours Cedex 9 : Centre Hospitalier Régional et Universitaire - Hôpital Bretonneau

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Germany

Coswig : Fachkrankenhaus Coswig

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Essen : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Freiburg : Universität Freiburg, Klinikum, Abt für Pneumologie

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Gießen : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Giessen : Philipps-Universität und Universitätsklinikum Gießen und Marburg GmbH

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Grosshansdorf : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Hannover : Klinik für Pneumologie, Medizinische Hochschule Hannover

A clinical study for patients with Idiopathic Pulmonary Fibrosis

Hanover : Medizinische Hochschule Hannover

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Heidelberg : Pneumologie und Beatmungsmedizin, Thoraxklinik,Universitätsklinikum

A clinical study for patients with Idiopathic Pulmonary Fibrosis

Heidelberg : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Heidelberg : Thoraxklinik am Universitätsklinikum Heidelberg

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Immenhausen : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Leipzig : Universitätsklinikum Leipzig

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Mannheim : Ruhrlandklinik

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

München : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

München : Klinikum Großhadern der Ludwig-Maximilians-Universität München

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

India

Thane : Kasiak Research Pvt Ltd

A clinical trial to evaluate treatments using Autologous Stromal Vascular Fraction (SVF), Autologous Adipose Derived MSCs (ADMSCs) and Control for patients with Idiopathic Pulmonary Fibrosis

Israel

Ashkelon : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Beer Sheva : Soroka University Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Haifa : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Jerusalem : Hadassah-Hebrew University Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Jerusalem : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

View More »

Kfar Saba : Meir Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Petach Tikva : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Petach Tikvah : Rabin Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Ramat-Gan : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Rehovot : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Tel Aviv : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Tel Hashomer : Chaim Sheba Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Italy

Catania : Regional Centre for Rare Lung Disease University of Catania.

A clinical study for patients with Idiopathic Pulmonary Fibrosis

Catania : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Monza : Azienda Ospedaliera San Gerardo di Monza

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Roma : Fondazione PTV - Policlinico Tor Vergata

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Siena : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Siena : Policlinico Le Scotte

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Japan

Fukuoka-shi : Research Site Updated

Patients are needed to participate in a clinical research study of tralokinumab cohort 1, tralokinumab cohort 2 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Himeji-shi : Research Site Updated

Patients are needed to participate in a clinical research study of tralokinumab cohort 1, tralokinumab cohort 2 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Seto-shi : Research Site Updated

Patients are needed to participate in a clinical research study of tralokinumab cohort 1, tralokinumab cohort 2 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Shibuya-ku : Research Site Updated

Patients are needed to participate in a clinical research study of tralokinumab cohort 1, tralokinumab cohort 2 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Yokohama-shi : Research Site Updated

Patients are needed to participate in a clinical research study of tralokinumab cohort 1, tralokinumab cohort 2 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Korea, Republic of

Bucheon-si : Soon Chun Hyang University Hospital Bucheon

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Incheon : Gachon University Gil Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Seongnam-si : Seoul National University Bundang Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Seoul : Asan Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Seoul : Korea University Anam Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Seoul : Samsung Medical Center

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Seoul : Seoul National University Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Seoul : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Netherlands

Rotterdam : Erasmus MC Rotterdam, Dep. of Pulmonology

A clinical study for patients with Idiopathic Pulmonary Fibrosis

Peru

Cercado de Lima : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Lima : Research Site Updated

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Poland

Bydgoszcz : 10 Wojskowy Szpital Kliniczny z Poliklinika SP ZOZ w Bydgoszczy

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Lodz : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Lódz : Samodzielny Publiczny ZOZ, Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Poznan : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Warszawa : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Warszawa : Instytut Gruzlicy i Chorób Pluc

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Zabrze : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Zabrze : Samodzielny Publiczny Szpital Kliniczny nr 3 w Zabrzu Slaskiego Uniwersytetu Medycznego w Katowicach

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Spain

Barcelona : Hospital Clínic i Provincial

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Barcelona : Hospital Universitario Vall d'Hebron

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Hospitalet de Llobregat : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Madrid : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Madrid : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Madrid : Hospital General Universitario Gregorio Marañon

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Madrid : Hospital Universitario La Princesa

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Pozuelo de Alarcón : Hospital Quirón Madrid

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Sevilla : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Valencia : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Switzerland

Basel : Universitätsspital Basel

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Lausanne : Centre Hospitalier Universitaire Vaudois Lausanne (CHUV)

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

St. Gallen : Kantonsspital St. Gallen

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

United Kingdom

Birmingham : Birmingham Heartlands Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Bristol : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Bristol : Southmead Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Cambridge : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Cambridge : Papworth Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More »

Cottingham : Castle Hill Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Edinburgh : Royal Infirmary of Edinburgh

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Glasgow : Glasgow Royal Infirmary

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Hampshire : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Leeds : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Leicester : Glenfield Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Liverpool : Aintree University Hospitals NHS Foundation Trust

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

London : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

London : Royal Brompton Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

London : GSK Investigational Site

A clinical trial to evaluate treatments using GSK2126458 and Placebo for patients with Idiopathic Pulmonary Fibrosis

London : GSK Investigational Site

A Phase 1 clinical study for patients with Idiopathic Pulmonary Fibrosis

London : Royal Brompton Hospital

Patients are needed to participate in a clinical research study evaluating Salbutamol for the treatment of Idiopathic Pulmonary Fibrosis

London : Royal Brompton Hospital

Patients are needed to participate in a clinical research study to evaluate Idiopathic Pulmonary Fibrosis or Idiopathic Non-specific Interstitial Pneumonitis

Manchester : Updated

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Manchester : University Hospital of South Manchester NHS Foundation Trust

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Norwich : Norfolk and Norwich University Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Nottingham : Nottingham City Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Nottingham : Nottingham University Hospitals NHS Trust

Patients are needed to participate in a clinical research study to evaluate Idiopathic Pulmonary Fibrosis

Oxford : Churchill Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Sheffield : Northern General Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Southampton : Southampton General Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis